Problems related to medical facilities and other health care

Z21_PROBL_RELATED_MEDICAL_FACILITI_OTH_HEALTH_CARE

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Z75 Cause of death: ICD-10 — Z75 2 out of 7 registries used, show all original rules.	2588
4. Check minimum number of events None	2588
5. Include endpoints None	2588
6. Filter based on genotype QC (FinnGen only)	2588

Control definitions (FinnGen only)

Control exclude: Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_OTH_CIRCUMSTANC1

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Z7

NAME	Z21_PROBL_RELATED_MEDICAL_FACILITI_OTH_HEALTH_CARE
CONTROL_EXCLUDE	Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_OTH_CIRCUMSTANC1
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Z75
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Z75
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Problems related to medical facilities and other health care based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	39465	20781	17877
Only index persons	26009	14602	11407
Unadjusted period prevalence (%)
Whole population	0.56	0.60	0.50
Only index persons	0.49	0.54	0.44
Median age at first event (years)
Whole population	78.09	79.68	76.23
Only index persons	76.87	78.62	74.62

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2588	1239	1349
Unadjusted period prevalence (%)	0.51	0.42	0.59
Median age at first event (years)	73.34	72.08	74.50

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2253: Matched controls
22436

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z75.2

ICD-10 Finland

Other waiting period for investigation and treatment

580.5

323.0

389

Z75.9

ICD-10 Finland

Unspecified problem related to medical facilities and other health care

4044.6

323.0

356

Z75.5

ICD-10 Finland

Holiday relief care

+∞

323.0

997

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

67.1

276.4

319

Z75.0

ICD-10 Finland

Medical services not available in home

348.2

164.1

164

Z75.8

ICD-10 Finland

Other problems related to medical facilities and other health care

639.7

124.3

122

N05AH04

ATC

quetiapine; oral

3.9

108.6

520

1601

N05AX08

ATC

risperidone; systemic

4.1

102.8

462

1338

N05BA04

ATC

oxazepam; oral

2.8

91.2

755

3406

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

3.4

72.3

404

1366

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.3

71.4

914

5080

N06AB04

ATC

citalopram; systemic

2.6

69.0

621

2857

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.3

62.3

247

618

N05AH03

ATC

olanzapine; systemic

5.8

61.3

184

340

N03AG01

ATC

valproic acid; systemic, rectal

5.0

61.2

208

444

A06AD11

ATC

lactulose; oral

2.4

60.3

642

3194

R53

ICD-10 Finland

Malaise and fatigue

2.4

59.0

618

3043

N06AX11

ATC

mirtazapine; oral

2.2

55.5

713

3856

N05AA02

ATC

levomepromazine; systemic

5.1

52.7

177

372

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

3.4

52.2

273

864

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.4

51.4

270

857

G30.1

ICD-10 Finland

Alzheimer disease with late onset

2.8

50.0

364

1445

N05CD07

ATC

temazepam; oral

2.3

48.8

523

2568

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.4

48.6

483

2283

F20.9

ICD-10 Finland

Schizophrenia, unspecified

13.8

47.1

Z71.8

ICD-10 Finland

Other specified counselling

3.1

46.2

281

989

N05AH02

ATC

clozapine; systemic

16.2

41.7

N05AD03

ATC

melperone; systemic

4.7

40.9

147

331

F0019, G301

ICD-10 Finland

5.7

40.9

122

223

F03

ICD-10 Finland

Unspecified dementia

2.7

39.7

305

1240

N05CF01

ATC

zopiclone; oral

1.9

39.4

860

5567

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.3

39.4

435

2138

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.5

39.4

335

1441

C03CA01

ATC

furosemide; systemic

1.8

39.2

1068

7450

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

4.0

38.8

166

442

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

38.1

423

2084

N05AF03

ATC

chlorprothixene; systemic

8.4

37.9

104

N05AX12

ATC

aripiprazole; systemic

7.8

37.7

118

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

37.7

805

5151

F29

ICD-10 Finland

Unspecified nonorganic psychosis

6.8

37.3

145

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.5

36.7

113

215

N05BA01

ATC

diazepam; systemic, rectal

2.3

36.3

365

1710

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

6.7

36.2

147

N06DX01

ATC

memantine; oral

2.4

36.2

329

1464

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.1

35.9

211

721

N06DA03

ATC

rivastigmine; oral, transdermal

3.0

34.9

213

746

N30.0

ICD-10 Finland

Acute cystitis

2.3

34.1

359

1717

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

7.2

33.9

120

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

3.2

33.4

188

622

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

33.3

678

4225

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

33.3

423

2200

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.9

33.1

213

772

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

3.3

31.9

171

546

N04AA02

ATC

biperiden; systemic

7.1

31.5

115

N06AX16

ATC

venlafaxine; oral

2.7

31.5

227

883

N05AA01

ATC

chlorpromazine; systemic, rectal

10.4

31.3

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

10.1

31.3

N05AD01

ATC

haloperidol; systemic

3.4

31.2

161

500

N06AB10

ATC

escitalopram; oral

2.2

30.6

349

1724

N06AB06

ATC

sertraline; oral

2.8

30.5

207

775

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.4

29.7

273

1215

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

3.7

29.6

136

385

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.0

29.4

408

2191

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.9

29.0

466

2646

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.2

28.9

160

523

Z75.4

ICD-10 Finland

Unavailability and inaccessibility of other helping agencies

+∞

28.1

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

28.0

404

2200

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

28.0

615

3890

SPAT1229

SPAT

Assessment of need for aid

2.5

27.7

236

1007

P29

ICPC

Psychological sympt/compl other

4.3

27.6

105

251

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.4

27.4

248

1092

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.4

27.4

138

421

F10.20

ICD-10 Finland

Alcohol dependence currently independent

7.5

27.3

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

7.5

27.3

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

6.0

26.9

127

N05AB03

ATC

perphenazine; systemic, rectal

4.1

26.6

107

270

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.4

26.6

238

1044

N05BA06

ATC

lorazepam; systemic, sublingual

2.9

26.5

173

632

N06AB03

ATC

fluoxetine; oral

2.4

26.3

242

1075

R50.9

ICD-10 Finland

Fever, unspecified

2.1

26.3

313

1570

SPAT1254

SPAT

Administration of medicine

2.0

26.0

394

2179

SPAT1251

SPAT

Organisation of medication

3.0

25.7

154

532

N05AF05

ATC

zuclopenthixol; systemic

11.9

25.6

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

18.8

25.6

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.8

25.4

173

649

LAITO

NOMESCO Finland

25.2

N06DA02

ATC

donepezil; oral

2.3

25.1

251

1159

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

25.1

389

2165

SPAT1301

SPAT

No procedures

1.7

24.7

632

4158

R11

ICD-10 Finland

Nausea and vomiting

2.4

24.5

217

945

R42

ICD-10 Finland

Dizziness and giddiness

1.8

24.2

516

3206

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

12.9

23.8

N02BE01

ATC

paracetamol; systemic, rectal

1.6

23.6

1642

13954

ICD-10 Finland

3.8

23.6

104

285

G20

ICD-10 Finland

Parkinson disease

3.1

22.7

129

429

J01MA02

ATC

ciprofloxacin; systemic

1.6

22.4

850

6191

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.2

22.3

249

1210

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

22.3

700

4852

N03AE01

ATC

clonazepam; systemic

2.9

22.2

139

495

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.5

22.2

106

311

N03AF01

ATC

carbamazepine; oral, rectal

2.7

22.1

161

628

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

22.0

295

1550

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.4

22.0

108

324

N05AN01

ATC

lithium; oral

6.4

21.7

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.5

21.6

173

713

N06AX21

ATC

duloxetine; oral

2.5

21.5

174

721

J01EA01

ATC

trimethoprim; systemic

1.6

21.2

632

4308

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.5

21.0

102

303

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

21.0

651

4480

SPAT1216

SPAT

Assessment of functional ability

1.8

20.8

371

2162

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

8.3

20.8

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

5.4

20.8

119

N30.9

ICD-10 Finland

Cystitis, unspecified

2.5

20.8

175

739

N05AC02

ATC

thioridazine; oral

5.1

20.6

129

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

20.4

367

2143

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.7

20.0

145

563

N03AX16

ATC

pregabalin; oral

1.8

19.9

402

2441

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.5

19.8

270

J01DA01

ATC

[U] cefalexin; systemic

1.5

19.8

1273

10374

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

3.1

19.7

114

385

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

19.7

447

2808

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

3.2

19.4

106

345

S06.0

ICD-10 Finland

Concussion

2.1

19.3

236

1189

N03AX09

ATC

lamotrigine; oral

4.1

19.3

194

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

19.1

311

1751

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

4.4

18.9

160

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

18.7

555

3758

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

3.6

18.6

246

SPAT1240

SPAT

Therapeutic discussion

2.5

18.5

147

603

Z2445

NOMESCO Finland

Psychologist

4.5

18.5

150

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

18.4

535

3598

N06AX03

ATC

mianserin; oral

2.8

18.4

124

461

F60.9

ICD-10 Finland

Personality disorder, unspecified

10.7

18.4

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

12.9

18.3

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.1

18.3

227

1150

R55

ICD-10 Finland

Syncope and collapse

1.9

18.2

290

1622

A28

ICPC

Limited function/disability NOS

1.7

18.1

422

2665

F61.0

ICD-10 Finland

Mixed personality disorders

8.9

18.1

A02BC03

ATC

lansoprazole; oral

1.6

17.9

602

4200

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.4

17.8

159

693

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.0

17.8

237

1237

A02BC01

ATC

omeprazole; systemic

1.6

17.7

624

4399

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

5.3

17.6

104

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.9

17.6

112

403

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.4

17.6

158

692

J01CA08

ATC

pivmecillinam; oral

1.5

17.5

782

5827

P70

ICPC

Dementia

2.9

17.4

106

371

P72

ICPC

Schizophrenia

7.4

17.4

A10AE04

ATC

insulin glargine; parenteral

2.1

17.3

209

1047

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.2

17.2

177

828

R06.0

ICD-10 Finland

Dyspnoea

1.6

17.1

495

3319

N03AX12

ATC

gabapentin; oral

2.0

17.0

243

1303

E000001

ATC

1.7

16.9

397

2511

E86

ICD-10 Finland

Volume depletion

3.0

16.7

341

Z74.1

ICD-10 Finland

Need for assistance with personal care

+∞

16.7

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

9.8

16.6

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

7.3

16.4

AA1AD

NOMESCO Finland

CT of head and brain

1.6

16.3

499

3386

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

14.3

16.3

SPAT1234

SPAT

Support of social functional capacity

2.3

16.2

160

733

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

10.4

16.1

R33

ICD-10 Finland

Retention of urine

1.9

16.1

234

1260

N06AG02

ATC

moclobemide; oral

3.1

15.9

305

SPAT1263

SPAT

Sampling

1.5

15.9

725

5398

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

15.8

566

3986

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.6

15.8

114

444

G30.0

ICD-10 Finland

Alzheimer disease with early onset

4.6

15.7

119

Z74.2

ICD-10 Finland

Need for assistance at home and no other household member able to render care

+∞

15.6

188

Kela drug reimbursment

Psychosis requiring demanding treatment

12.9

15.6

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.9

15.6

167

Z50.1

ICD-10 Finland

Other physical therapy

2.5

15.6

123

505

N05BA12

ATC

alprazolam; oral

2.0

15.4

193

984

R41.0

ICD-10 Finland

Disorientation, unspecified

2.5

15.3

121

496

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.0

15.3

155

Z02.4

ICD-10 Finland

Examination for driving licence

0.5

15.1

142

2594

NGA20

NOMESCO Finland

Exploration of soft tissue knee or lower leg, open

17.8

15.1

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

10.1

14.9

G04CA02

ATC

tamsulosin; oral

1.5

14.9

581

4168

N06AA12

ATC

doxepin; systemic

2.3

14.8

140

627

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.1

14.8

145

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

14.7

175

874

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

10.4

14.7

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

14.6

195

1017

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

5.6

14.6

R51.80

ICD-10 Finland

Headache

1.9

14.6

215

1166

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

5.1

14.5

B01AC07

ATC

dipyridamole; systemic

1.8

14.4

243

1380

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.4

14.3

127

554

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.4

14.3

206

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

14.3

291

1758

N18

ICPC

Paralysis/weakness

4.0

14.2

141

N06AA09

ATC

amitriptyline; systemic

2.0

14.2

198

1048

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.7

14.2

373

N04BD01

ATC

selegiline; oral

3.7

14.0

163

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

8.0

14.0

C07AB02

ATC

metoprolol; systemic

1.5

13.9

606

4439

N28

ICPC

Limited function/disability (N)

4.7

13.9

102

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

5.5

13.8

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

13.8

534

3815

N02AA05

ATC

oxycodone; systemic

1.7

13.8

340

2172

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.9

13.7

204

1108

N07BB01

ATC

disulfiram; oral

3.6

13.6

167

D01AC02

ATC

miconazole; topical

1.9

13.6

199

1076

E66.9

ICD-10 Finland

Obesity, unspecified

3.7

13.5

158

F10.09

ICD-10 Finland

Alcohol intoxication UNS

5.1

13.5

N05BE01

ATC

buspirone; oral

3.6

13.4

169

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

13.4

182

955

P15

ICPC

Chronic alcohol abuse

5.1

13.3

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

2.9

13.2

285

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

4.2

13.2

117

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

13.8

13.2

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

13.2

320

2034

F0009, G300

ICD-10 Finland

5.9

13.1

A10BB01

ATC

glibenclamide; oral

1.8

13.1

221

1257

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

10.1

12.9

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

12.9

156

784

G04BD04

ATC

oxybutynin; oral, transdermal

2.0

12.9

178

940

P99

ICPC

Psychological disorders other

4.7

12.8

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

50.1

12.8

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

12.8

762

5926

J01XX05

ATC

methenamine; oral

3.3

12.6

194

J01AA02

ATC

doxycycline; systemic

1.4

12.6

1444

12589

A10BB12

ATC

glimepiride; oral

1.8

12.5

237

1399

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

5.3

12.5

Z74.8

ICD-10 Finland

Other problems related to care-provider dependency

+∞

12.5

I50.0

ICD-10 Finland

Congestive heart failure

1.7

12.4

294

1852

SPAT1262

SPAT

Handing over of treatment supplies

1.6

12.3

315

2027

L28

ICPC

Limited function/disability (L)

1.6

12.3

346

2284

J01DB01

ATC

cefalexin; oral

1.4

12.3

1417

12336

W19

ICD-10 Finland

Unspecified fall

1.8

12.3

205

1159

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

7.1

12.2

Z72.1

ICD-10 Finland

Alcohol use

14.3

12.2

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

8.4

12.2

A10AE05

ATC

insulin detemir; parenteral

2.2

12.2

118

538

F41.1

ICD-10 Finland

Generalized anxiety disorder

3.2

12.2

205

P01

ICPC

Feeling anxious/nervous/tense

2.3

12.2

112

498

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

6.4

12.1

G82.2

ICD-10 Finland

Paraplegia, unspecified

12.4

12.1

R52.2

ICD-10 Finland

Other chronic pain

3.4

12.0

175

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.4

12.0

102

435

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

12.0

642

4878

B01AA03

ATC

warfarin; systemic

1.4

12.0

620

4681

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

11.9

555

4104

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

11.8

645

4918

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

6.4

11.8

F20.5

ICD-10 Finland

Residual schizophrenia

11.7

11.8

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.2

11.7

107

F10.25

ICD-10 Finland

Alcohol dependence continuous use

5.9

11.7

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.6

11.7

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.7

11.7

292

M54.5

ICD-10 Finland

Low back pain

1.5

11.7

459

3276

A02BA02

ATC

ranitidine; systemic

1.5

11.6

457

3263

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

65.0

11.6

D07AA02

ATC

hydrocortisone; topical

1.7

11.6

250

1536

A10BA02

ATC

metformin; oral

1.4

11.6

579

4339

K59.0

ICD-10 Finland

Constipation

2.0

11.5

149

766

N03AF02

ATC

oxcarbazepine; oral

3.0

11.5

214

F34.1

ICD-10 Finland

Dysthymia

3.6

11.5

139

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.8

11.5

200

1146

G91.0

ICD-10 Finland

Communicating hydrocephalus

7.1

11.5

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

6.2

11.5

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

4.4

11.5

M03BX01

ATC

baclofen; systemic

4.5

11.4

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.8

11.3

204

1186

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

11.3

252

1562

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

35.0

11.2

F009, G309

ICD-10 Finland

4.0

11.2

112

H90.5

ICD-10 Finland

Sensorineural hearing loss, unspecified

4.8

11.1

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.5

11.1

B01AC06

ATC

acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)

1.8

11.1

184

1039

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

11.1

11.0

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

11.1

11.0

F20.0

ICD-10 Finland

Paranoid schizophrenia

11.1

11.0

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

7.1

11.0

2953C

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN]

43.3

10.9

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

43.3

10.9

A46

ICD-10 Finland

Erysipelas

1.6

10.9

291

1895

G04BD07

ATC

tolterodine; oral

1.9

10.8

150

795

Z71.9

ICD-10 Finland

Counselling, unspecified

2.6

10.8

301

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

10.8

454

3278

A10AA02

ATC

2.2

10.7

108

503

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.5

10.7

351

F99

ICD-10 Finland

Mental disorder, not otherwise specified

4.8

10.6

A01

ICPC

Pain general/multiple sites

2.0

10.6

134

685

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

3.1

10.6

187

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.0

10.6

142

743

Z00.8

ICD-10 Finland

Other general examinations

2.1

10.5

113

541

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.8

10.5

232

F10.24

ICD-10 Finland

Alcohol depence active use

6.5

10.4

R13

ICD-10 Finland

Dysphagia

2.0

10.4

126

633

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

5.0

10.4

Z75

ICD-10 Finland

Problems related to medical facilities and other health care

110.0

10.4

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

10.4

467

3416

D64.9

ICD-10 Finland

Anaemia, unspecified

1.6

10.4

254

1612

N05AC01

ATC

periciazine; systemic

5.4

10.4

S01.0

ICD-10 Finland

Open wound of scalp

1.9

10.3

158

869

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

32.5

10.3

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.4

10.3

142

R1250

NOMESCO Finland

Evaluation of functional capability

4.4

10.3

A01AB09

ATC

miconazole; local oral

1.7

10.2

203

1216

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

5.7

10.2

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

23.4

10.2

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

4.7

10.2

A41.9

ICD-10 Finland

Sepsis, unspecified

2.2

10.2

101

466

E000006

ATC

2.0

10.2

135

706

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

10.1

276

1802

Z60.8

ICD-10 Finland

Other problems related to social environment

7.5

10.1

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.6

10.1

288

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

10.1

210

1272

N07AA05

ATC

8.4

10.0

P76

ICPC

Depressive disorder

2.7

10.0

260

N06AB08

ATC

fluvoxamine; oral

3.4

9.8

137

F31.8

ICD-10 Finland

Other bipolar affective disorders

6.3

9.8

P28

ICPC

Limited function/disability (P)

6.3

9.8

SPAT1265

SPAT

Breathalyser

8.1

9.8

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

9.8

320

2183

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

26.0

9.8

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

4.1

9.8

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.3

9.8

369

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

7.4

9.7

ZY000

NOMESCO Finland

Hospital inpatient

7.4

9.7

N02AX02

ATC

tramadol; systemic, rectal

1.4

9.6

759

6119

SPAT1307

SPAT

Psychosocial counselling and guidance

2.5

9.6

297

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

9.6

124

641

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.5

9.6

309

J45.1

ICD-10 Finland

Nonallergic asthma

2.0

9.6

126

657

R60.0

ICD-10 Finland

Localized oedema

1.7

9.5

201

1225

KMAK

NOMESCO Finland

1.4

9.5

667

5280

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

6.0

9.5

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

9.4

708

5663

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.4

9.4

332

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

4.2

9.4

P03

ICPC

Feeling depressed

2.2

9.4

417

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

9.4

103

500

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

6.2

9.3

2959A

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]

21.7

9.3

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

21.7

9.3

R52.1

ICD-10 Finland

Chronic intractable pain

5.8

9.3

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.4

9.3

338

S70.0

ICD-10 Finland

Contusion of hip

2.1

9.3

102

493

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

9.3

273

1817

A03FA02

ATC

cisapride; oral, rectal

1.7

9.3

194

1178

F06.7

ICD-10 Finland

Mild cognitive disorder

2.4

9.3

321

ZY010

NOMESCO Finland

Hospital outpatient

2.8

9.3

217

Z50.5

ICD-10 Finland

Speech therapy

4.9

9.2

N05BA02

ATC

chlordiazepoxide; systemic

2.9

9.2

182

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

6.0

9.2

Z60.9

ICD-10 Finland

Problem related to social environment, unspecified

6.0

9.2

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

6.0

9.2

-1

NOMESCO Finland

1.5

9.2

397

2878

P01AB01

ATC

metronidazole; oral, rectal

1.4

9.1

586

4562

Z00.0

ICD-10 Finland

General medical examination

1.6

9.1

271

1805

E66.01

ICD-10 Finland

Obesity due to excess calories

2.3

9.0

359

J02AC01

ATC

fluconazole; systemic

1.4

9.0

531

4072

C07AA05

ATC

propranolol; systemic

1.6

9.0

267

1781

E0000UV

ATC

1.4

9.0

635

5020

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

9.0

118

616

K92.0

ICD-10 Finland

Haematemesis

2.5

9.0

293

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.7

9.0

186

1127

A98

ICPC

Health maint/preventive medicine

0.8

8.9

1247

13897

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

8.9

254

1678

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

8.9

144

809

J01FA06

ATC

roxithromycin; oral

1.3

8.9

708

5707

ZYC01

NOMESCO Finland

Remote contact by phone

2.8

8.8

195

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

1.8

8.8

136

753

R07.3

ICD-10 Finland

Other chest pain

1.8

8.8

161

943

SPAT1279

SPAT

Preparation of immediate hospitalisation

3.1

8.8

150

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.8

8.7

155

895

UJF32

NOMESCO Finland

Coloscopy

1.4

8.7

423

3130

SPAT1304

SPAT

Counselling and guidance related to ageing

1.7

8.7

172

1030

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.2

8.7

377

E66.8

ICD-10 Finland

Other obesity

2.9

8.7

179

F21

ICD-10 Finland

Schizotypal disorder

14.0

8.7

N06AX12

ATC

bupropion; oral

2.7

8.6

209

N06AB05

ATC

paroxetine; oral

2.3

8.6

358

N06DA04

ATC

galantamine; oral

2.2

8.6

368

F43.1

ICD-10 Finland

Post-traumatic stress disorder

4.1

8.6

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

5.5

8.6

F41.09

ICD-10 Finland

UNS Panic Syndrome

4.2

8.5

F05.9

ICD-10 Finland

Delirium, unspecified

2.5

8.5

265

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.4

8.5

303

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.5

8.5

248

M79.6

ICD-10 Finland

Pain in limb

1.4

8.4

495

3789

S72.0

ICD-10 Finland

Fracture of neck of femur

1.8

8.4

152

883

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.8

8.4

193

F32.1

ICD-10 Finland

Moderate depressive episode

2.4

8.4

269

F32.8

ICD-10 Finland

Other depressive episodes

4.8

8.3

M02AA07

ATC

piroxicam; topical

1.3

8.3

708

5751

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.7

8.3

196

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

8.3

420

3130

205

Kela drug reimbursment

Chronic hypertension

1.3

8.2

750

6152

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

7.1

8.2

P74

ICPC

Anxiety disorder/anxiety state

3.0

8.2

152

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

8.2

109

571

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

8.1

153

901

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

5.1

8.1

A02BC02

ATC

pantoprazole; systemic

1.3

8.1

1093

9457

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

5.7

8.1

F90.0

ICD-10 Finland

Disturbance of activity and attention

4.3

8.1

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.6

8.1

206

1323

F60.2

ICD-10 Finland

Dissocial personality disorder

33.3

8.1

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.6

8.1

218

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

17.1

8.1

C08CA02

ATC

felodipine; oral

1.6

8.0

228

1504

SPAT1167

SPAT

Insertion of urinary catheter

2.1

8.0

414

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.2

8.0

127

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

8.0

238

1590

R10.0

ICD-10 Finland

Acute abdomen

2.5

7.9

240

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

3.4

7.9

107

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

5.7

7.8

K07.60

ICD-10 Finland

Snapping jaw

2.5

7.8

227

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.3

7.8

WVA30

SPAT

2.8

7.7

170

P20

ICPC

Memory disturbance

1.5

7.7

283

1979

N05AL01

ATC

sulpiride; systemic

3.1

7.6

126

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.6

7.6

175

1094

A34

ICPC

General and Unspecified, Blood test

3.2

7.6

121

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

18.3

7.6

F25.2

ICD-10 Finland

Schizoaffective disorder, mixed type

18.3

7.6

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

25.0

7.6

G04BD08

ATC

solifenacin; oral

1.8

7.5

134

777

N03AB02

ATC

phenytoin; systemic

3.0

7.5

133

F93.89

ICD-10 Finland

Other childhood emotional disorders

10.0

7.5

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.8

7.5

168

J01MA12

ATC

levofloxacin; systemic

1.4

7.5

346

2533

A12BA01

ATC

potassium chloride; oral

1.6

7.4

193

1244

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

2.3

7.4

299

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

4.8

7.4

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.8

7.4

120

674

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.3

7.4

107

A02BC05

ATC

esomeprazole; systemic

1.3

7.4

628

5080

90621

NOMESCO Finland

6.4

7.4

G30.8

ICD-10 Finland

Other Alzheimer disease

2.1

7.4

403

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

7.4

182

1161

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

13.3

7.4

F61

ICD-10 Finland

Mixed and other personality disorders

13.3

7.4

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

7.6

7.4

IGY02

NOMESCO Finland

Psychiatric monitoring contact

4.5

7.3

EBA00

NOMESCO Finland

Extraction of tooth

1.4

7.3

432

3301

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

5.6

7.3

I20.90

ICD-10 Finland

Angina pectoris, unspecified

1.8

7.3

119

671

G47.9

ICD-10 Finland

Sleep disorder, unspecified

3.1

7.3

125

F60.0

ICD-10 Finland

Paranoid personality disorder

10.8

7.3

I95.1

ICD-10 Finland

Orthostatic hypotension

1.9

7.3

504

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.8

7.3

153

29599

ICD-8 Finland

Schizophrenia, Unspecified type

9.3

7.3

A01AB04

ATC

amphotericin B; local oral

1.8

7.2

121

690

C01CA01

ATC

etilefrine; systemic

3.1

7.2

120

WYA20

NOMESCO Finland

Home visit

2.4

7.2

238

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.7

7.1

144

867

SPAT1255

SPAT

Intravenous administration of medicine

1.9

7.1

108

594

C01DA14

ATC

isosorbide mononitrate; oral

1.3

7.1

544

4334

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

7.1

219

1473

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

7.1

117

663

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

12.0

7.1

SPAT1247

SPAT

Outpatient detoxication and monitoring

12.0

7.1

P80

ICPC

Personality disorder

12.0

7.1

M54.2

ICD-10 Finland

Cervicalgia

2.0

7.1

466

B18.2

ICD-10 Finland

Chronic viral hepatitis C

6.0

7.0

F41.8

ICD-10 Finland

Other specified anxiety disorders

3.9

7.0

G47.3

ICD-10 Finland

Sleep apnoea

1.5

7.0

234

1601

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

7.0

269

1899

T74.1

ICD-10 Finland

Physical abuse

4.7

7.0

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

7.0

321

R40.0

ICD-10 Finland

Somnolence

7.0

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

7.0

179

1152

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

3.5

6.9

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

6.9

120

693

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.2

6.9

303

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

6.9

452

3510

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

13.7

6.9

F20.10

ICD-10 Finland

Raise schizophrenia continuously

13.7

6.9

N06AA06

ATC

trimipramine; systemic

2.9

6.9

141

Z51.88

ICD-10 Finland

Other specified medical care

2.9

6.9

141

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

4.0

6.8

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

6.8

481

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

4.4

6.8

B37.2

ICD-10 Finland

Candidiasis of skin and nail

8.2

6.8

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

8.2

6.8

N06AX26

ATC

vortioxetine; oral

2.2

6.8

286

Z29

ICPC

Social problem NOS

2.7

6.8

155

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.0

6.8

404

Z01.7

ICD-10 Finland

Laboratory examination

1.6

6.8

152

944

D11

ICPC

Diarrhoea

1.7

6.8

134

805

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

9.3

6.8

ZXD20

NOMESCO Finland

Day surgery

1.5

6.8

207

1392

N05BB01

ATC

hydroxyzine; systemic

1.7

6.8

125

734

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

2.3

6.7

268

2953E

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]

16.7

6.7

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

4.3

6.7

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3009466) Valproate [Moles/volume] in Serum or Plasma

179

5.57

50.05

6.6

3.8

umol/l

376.8

346.6

1.08

158

(3028707) Methadone [Presence] in Urine by Screen method

120

6.03

40.14

3.2

1.9

—

(3019150) Specific gravity of Urine by Refractometry

614

3745

1.83

34.32

6.5

4.5

kg/l

1.0

0.84

560

(3011288) Drugs identified in Urine by Screen method

209

3.80

25.42

4.3

2.1

—

(3029937) Albumin [Presence] in Urine by Test strip

616

4126

1.64

23.33

6.3

4.3

estimate

0.0

0.88

105

1077

(1001926) Buprenorphine [Presence] in Urine by Screen method

240

3.35

21.37

3.3

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

812

5940

1.53

20.59

6.3

4.4

—

(3016879) Cocaine [Presence] in Urine

300

2.89

17.88

3.3

1.7

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

220

1188

1.92

17.29

6.4

5.9

mmol/l

24.9

24.5

0.88

214

1107

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1193

14185

0.70

17.28

4.8

4.7

mmol/l

2.6

1.12

1097

12611

(3000764) Benzodiazepines [Presence] in Urine

324

2.77

17.12

3.3

1.6

—

(3027944) Amphetamines [Presence] in Urine

326

2.75

16.93

3.6

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

216

1170

1.92

16.81

2.9

1.6

1.5

0.20

182

995

(3027008) Opiates [Presence] in Urine

328

2.70

16.19

3.3

1.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1138

13564

0.71

16.16

4.2

mmol/l

1.4

8.19

1051

12032

(3028300) Cannabinoids [Presence] in Urine

331

2.68

15.91

3.5

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1157

13731

0.71

15.87

4.3

4.2

mmol/l

4.4

4.5

1.63

1072

12302

(40761535) Cells panel - Urine sediment

262

1545

1.77

15.50

4.8

3.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

134

633

2.17

15.19

3.8

3.5

mmol/l

1.5

1.4

0.40

128

626

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1099

13067

0.72

14.68

3.9

3.8

mmol/l

1.3

3.03

1006

11491

(3016502) Oxygen saturation in Arterial blood

283

1740

1.70

14.40

5.7

5.9

94.3

95.2

1.21

275

1661

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1830

0.42

13.90

3.5

4.3

33.9

33.1

0.31

1148

(3003396) Base excess in Arterial blood by calculation

314

2002

1.64

13.88

5.7

5.6

mmol/l

1.9

1.3

2.15

252

1501

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

642

4782

1.45

13.87

3.0

2.3

u/l

65.6

56.6

0.46

598

4347

(3040151) Glucose [Moles/volume] in Capillary blood

229

2.88

13.78

118.5

8.1

mmol/l

7.1

7.8

1.26

187

(3043409) Potassium [Moles/volume] in Arterial blood

121

573

2.16

13.65

4.1

3.5

mmol/l

4.0

3.9

0.46

103

521

(3035350) Ketones [Presence] in Urine by Test strip

946

7565

1.39

13.59

5.9

4.0

estimate

0.0

0.00

124

1138

(3021601) Nitrite [Presence] in Urine by Test strip

945

7556

1.39

13.59

7.5

5.5

estimate

0.0

0.00

122

1136

(3009261) Glucose [Presence] in Urine by Test strip

954

7657

1.38

13.34

6.0

4.1

estimate

0.0

0.80

116

1119

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1128

13220

0.73

12.94

20.1

14.7

ml/min/173m2

79.0

73.7

8.76

858

10668

(3011397) Hemoglobin [Presence] in Urine by Test strip

514

3722

1.47

12.73

5.7

4.1

—

(3023368) Bacteria identified in Blood by Culture

664

5056

1.42

12.51

4.9

4.0

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

417

2.29

12.45

3.4

3.3

mmol/l

25.1

25.2

0.09

356

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

592

4421

1.43

12.42

4.1

3.0

u/l

33.4

34.5

0.18

564

4147

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

304

1979

1.60

12.30

5.7

kpa

5.2

5.0

0.98

294

1846

(3027801) Oxygen [Partial pressure] in Arterial blood

303

1978

1.60

12.11

5.7

kpa

11.5

11.6

0.06

294

1844

(3026008) Bacteria identified in Urine by Culture

727

5665

1.39

11.86

4.9

3.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

248

1578

1.63

10.99

5.9

6.3

g/l

121.7

119.5

1.01

242

1515

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1160

13334

0.76

10.55

7.1

6.0

mmol/mol

43.1

40.8

7.90

1087

11944

(4198724)

6.97

10.53

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

821

6623

1.34

10.50

5.2

4.2

ng/l

53.5

63.5

0.49

600

4865

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

209

1292

1.67

10.38

1.9

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

312

2144

1.51

9.86

1.7

1.8

—

(3019060) Gas panel - Arterial blood

199

1233

1.66

9.80

4.7

4.0

—

(3025941) Bacteria identified in Stool by Culture

136

758

1.83

9.73

1.4

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

182

2865

0.61

9.67

2.5

3.1

ug/l

0.9

0.01

115

1986

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

259

1722

1.55

9.52

3.2

2.4

ug/l

5.1

6.3

0.81

208

1369

(3051387) C reactive protein [Mass/volume] in Capillary blood

491

2.01

9.27

5.6

3.8

mg/l

31.3

29.8

0.12

355

(3009542) Hematocrit [Volume Fraction] of Blood

1205

13658

0.77

9.22

24.9

17.2

37.8

38.0

0.16

718

8699

(3014576) Chloride [Moles/volume] in Serum or Plasma

297

2056

1.50

9.04

6.0

5.5

mmol/l

103.1

104.3

3.93

275

1989

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

151

896

1.72

8.75

3.8

2.1

1.5

1.1

3.63

151

891

(3006184) Hemoglobin [Mass/volume] in Capillary blood

374

2.11

8.64

1.9

2.2

g/l

125.9

125.7

0.03

278

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

172

1069

1.65

8.39

1.7

1.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1260

14108

0.79

8.27

4.7

4.6

mmol/l

6.2

6.0

3.18

1156

12357

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

129

752

1.75

7.99

2.0

1.8

ug/l

2.9

3.1

0.05

116

616

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

341

2.11

7.86

2.7

2.0

u/l

14104.6

5399.5

0.48

147

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

301

2147

1.45

7.85

1.7

1.8

—

(3021901) Oxygen saturation in Capillary blood

302

2.14

7.43

2.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1424

15626

0.80

7.40

11.6

9.5

u/l

24.3

24.4

0.04

1349

14774

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

106

598

1.80

7.36

1.3

1.2

—

(3020891) Body temperature

123

729

1.72

7.21

5.1

4.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

608

4920

1.30

7.13

2.5

2.0

u/l

302.5

232.2

0.56

545

4541

(3000850) Epithelial cells [#/volume] in Urine

448

3477

1.34

7.05

3.8

2.6

e6/l

6.9

5.5

0.97

415

3074

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

482

3782

1.33

7.05

1.8

1.7

pmol/l

390.7

10378408.9

1.53

413

3016

(3036481) Cortisol [Moles/volume] in Serum or Plasma

184

1218

1.54

6.92

1.8

1.9

nmol/l

412.5

379.9

0.36

169

1072

(3013512) EKG study

353

4590

0.73

6.91

4.9

4.1

—

(3002032) Base excess in Venous blood by calculation

244

1718

1.46

6.81

4.9

3.0

mmol/l

2.7

1.9

1.87

204

1325

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

7.14

6.67

2.4

2.1

umol/l

17.7

14.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

243

1722

1.45

6.56

4.8

3.0

kpa

6.0

5.8

1.45

236

1652

(4146454)

161

0.00

6.51

0.0

2.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

258

1856

1.43

6.43

2.1

1.7

—

(3010813) Leukocytes [#/volume] in Blood

1534

16583

0.81

6.36

33.7

22.8

e9/l

7.2

7.0

4.49

1467

15822

(3026361) Erythrocytes [#/volume] in Blood

1535

16574

0.81

6.19

33.7

22.8

e12/l

4.3

4.4

1.74

1464

15820

(3035941) MCH [Entitic mass]

1535

16573

0.81

6.18

33.5

22.7

30.1

30.3

4.84

1473

16080

(3024731) MCV [Entitic volume]

1535

16572

0.81

6.17

33.5

22.8

90.8

91.3

2.88

1473

16082

(3000963) Hemoglobin [Mass/volume] in Blood

1536

16578

0.81

6.14

33.9

23.0

g/l

129.2

131.4

6.39

1478

16093

(3007461) Platelets [#/volume] in Blood

1535

16567

0.81

6.13

33.6

22.8

e9/l

247.9

243.8

1.49

1470

15882

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

399

3114

1.33

6.00

1.9

1.7

mg/l

1.3

1.4

0.20

320

2410

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.34

5.96

3.0

2.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.34

5.96

3.0

2.0

—

(3019225) pH of Specimen

1603

0.60

5.88

3.2

4.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

205

2.21

5.77

1.2

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

207

1459

1.45

5.77

4.1

2.5

kpa

4.3

4.4

0.28

201

1396

(3044242) Glucose [Moles/volume] in Arterial blood

3.03

5.61

1.7

2.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

205

1453

1.44

5.55

5.7

5.1

mmol/l

1.5

0.32

197

1380

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

834

0.47

5.54

1.3

1.7

—

(3012544) pH of Venous blood

242

1769

1.40

5.52

4.7

3.0

—

7.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

3.34

5.41

3.4

2.8

umol/l

33.0

29.9

0.76

(40768797) Stomach Pathology biopsy report

237

1734

1.40

5.38

1.2

—

(3000991) Gas panel - Venous blood

194

1370

1.44

5.37

7.4

6.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

378

1.84

5.36

1.9

2.2

ug/min

70.4

81.0

0.14

220

(3024561) Albumin [Mass/volume] in Serum or Plasma

823

7106

1.23

5.31

4.7

4.3

g/l

34.0

34.3

1.03

747

6392

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

5.55

5.30

1.4

1.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

5.55

5.30

1.4

1.1

103.0

—

(3020779) Urea [Moles/volume] in Serum or Plasma

198

1416

1.43

5.12

5.9

5.3

mmol/l

11.3

11.9

0.44

186

1302

(3005322) IgE [Units/volume] in Serum or Plasma

108

680

1.61

5.11

1.3

1.2

u/ml

160.2

205.0

0.49

621

(3018418) pH of Serum or Plasma

575

4803

1.25

5.01

4.3

3.5

7.4

0.70

787

(21494755) Public health laboratory ask at order entry panel

893

0.52

4.97

1.3

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

2.70

4.97

1.5

1.2

promille

1.1

0.9

0.19

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1455

15649

0.83

4.96

26.3

18.2

umol/l

82.8

83.2

0.16

1455

15641

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

240

2.01

4.90

1.4

1.2

e6/l

7.0

33.8

0.71

200

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

240

2.01

4.90

1.4

1.3

e6/l

194.5

944.9

0.79

204

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

432

5239

0.79

4.90

4.1

5.3

ug/l

6.1

5.2

0.12

381

4562

(40760892) CBC W Ordered Manual Differential panel - Blood

363

2878

1.30

4.84

4.5

4.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

381

3048

1.29

4.74

1.9

1.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

359

1.80

4.65

1.7

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

475

3915

1.26

4.63

5.4

3.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

324

1.83

4.60

2.2

1.6

mu/l

452.0

280.5

1.20

290

(3023183) Ammonium ion [Moles/volume] in Plasma

289

1.88

4.56

1.7

2.4

umol/l

33.8

31.9

0.13

219

(3048689) Calprotectin [Mass/mass] in Stool

182

1311

1.41

4.55

2.2

2.1

ug/g

105.3

154.0

2.27

145

1013

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

452

1.70

4.52

1.9

1.8

—

(3002582) Erythrocytes [#/volume] in Urine

574

4861

1.23

4.34

4.3

3.2

e6/l

49.6

107.7

1.18

478

3779

(40761511) CBC panel - Blood by Automated count

1453

15547

0.84

4.34

20.2

15.5

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1206

10941

1.18

4.33

7.4

5.0

e6/l

1728.1

2678.0

0.52

247

(3003458) Phosphate [Moles/volume] in Serum or Plasma

271

2097

1.32

4.32

5.3

4.5

mmol/l

1.1

1.0

0.99

251

1863

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

3.20

4.31

1.7

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

432

1.68

4.17

1.3

1.2

—

(3004775) Volume in Urine collected for unspecified duration

109

2.39

4.11

1.7

2.1

553.8

553.9

0.00

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

315

1.79

4.08

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

436

1.66

4.04

1.3

1.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

899

7991

1.19

4.02

5.6

5.3

umol/l

11.2

12.6

1.74

833

7431

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

273

1.84

4.01

1.3

1.2

mg/l

427.8

528.3

1.24

257

(3006270) Folate [Moles/volume] in Blood

203

1.98

3.98

1.3

1.2

nmol/l

343.9

323.5

0.22

163

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

431

1.66

3.96

1.3

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

2.53

3.93

1.3

1.2

g/l

7.9

6.7

0.67

(3028192) IgG subclass 2 [Mass/volume] in Serum

2.53

3.93

1.3

1.2

g/l

3.0

2.7

0.37

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

554

0.46

3.92

1.1

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

198

1.98

3.89

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

213

1.93

3.83

1.7

1.5

—

(3018095) Leukocytes [#/volume] in Urine

649

5641

1.20

3.70

4.9

3.6

e6/l

119.2

127.7

0.10

504

4076

(3017143) Hepatitis C virus Ab [Presence] in Serum

171

1269

1.37

3.63

1.9

1.5

—

(3047181) Lactate [Moles/volume] in Blood

560

1.55

3.62

5.2

mmol/l

1.3

0.09

489

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

136

972

1.42

3.61

2.3

1.9

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

3.25

3.60

1.5

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

252

1984

1.29

3.57

2.1

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

214

1652

1.32

3.50

2.8

2.5

umol/l

10.6

10.1

0.07

179

1404

(3045716) Anion gap in Serum or Plasma

3.04

3.50

1.4

1.6

mmol/l

8.7

9.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

330

2694

1.25

3.48

27.3

30.7

inr

1.5

0.03

264

(40758558) Short blood count panel - Blood

439

3700

1.22

3.44

8.2

5.8

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.89

3.44

2.1

1.7

umol/l

83.8

122.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

120

848

1.43

3.41

6.6

7.9

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

194

1.91

3.40

1.8

1.2

—

(3044889) 12 lead EKG panel

935

10229

0.86

3.31

4.3

4.1

—

(4062490)

2.36

3.29

1.4

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.02

3.23

1.2

1.1

—

(3001604) Monocytes [#/volume] in Blood

794

7097

1.17

3.17

6.7

4.9

e9/l

0.6

0.00

706

5977

(3019309) Folate [Moles/volume] in Red Blood Cells

474

4058

1.20

3.15

1.9

1.8

nmol/l

1328.2

1157.4

3.97

393

2951

(1616796) Gas panel - Central venous blood

334

1.65

3.13

4.5

3.5

—

(40768804) Tissue Pathology biopsy report

478

5497

0.84

3.11

2.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

134

985

1.38

3.06

3.5

3.8

mmol/l

2.9

2.2

1.10

100

702

(3006315) Basophils [#/volume] in Blood

796

7133

1.16

3.06

6.7

4.9

e9/l

0.0

0.84

709

6023

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

4.99

3.04

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

112

2.15

3.04

1.1

—

(3010421) pH of Blood

423

1.57

3.03

5.5

3.8

7.4

0.59

349

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1266

13494

0.87

2.99

5.5

4.5

mu/l

2.0

2.2

1.07

1171

11944

(3042936) Bacteria identified in Isolate by Culture

270

2195

1.25

2.97

2.2

1.9

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

9.98

2.97

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

100

2.20

2.97

1.4

1.2

—

(3019198) Lymphocytes [#/volume] in Blood

817

7354

1.16

2.93

6.9

5.0

e9/l

1.8

0.94

734

6316

(3044290) Cell count panel - Cerebral spinal fluid

210

1.77

2.72

1.3

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

290

2405

1.23

2.68

2.7

mmol/l

0.8

0.34

275

2152

(3003181) Sodium [Moles/volume] in Urine

311

1.61

2.64

1.7

1.3

mmol/l

57.6

60.3

0.21

242

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

119

2.02

2.63

1.2

1.4

15.0

22.0

0.94

(3013115) Eosinophils [#/volume] in Blood

815

7385

1.15

2.62

7.5

5.1

e9/l

0.2

0.18

736

6320

(1761868) Lipid panel - Serum or Plasma

358

4162

0.83

2.61

3.2

3.0

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

294

2450

1.22

2.59

2.1

2.0

29.4

30.1

1.19

280

2360

(40757373) Influenza virus identified in Isolate

2.54

2.59

1.4

1.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1016

9348

1.14

2.59

6.6

4.3

mmol/l

7.1

6.9

1.84

955

8641

(3015377) Calcium [Moles/volume] in Serum or Plasma

625

5567

1.16

2.55

3.0

3.1

mmol/l

2.3

0.19

559

4645

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

135

1026

1.33

2.54

3.7

3.8

kpa

5.3

5.2

0.47

129

917

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

567

1.44

2.50

1.1

1.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

403

4618

0.85

2.48

3.6

3.7

mg/mmol

10.2

10.3

0.01

256

2875

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

140

1074

1.32

2.47

2.5

2.1

—

(3009343) pH of Capillary blood

133

1014

1.32

2.46

3.7

3.8

7.4

0.43

108

(3037522) Nuclear Ab [Titer] in Serum

189

1513

1.26

2.41

1.3

titre

230.0

560.8

7.25

304

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

269

2239

1.22

2.41

13.0

9.2

—

(3044927) Protein electrophoresis panel - Urine

188

0.37

2.40

1.3

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

108

801

1.36

2.40

1.5

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

190

0.37

2.40

1.4

1.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

364

4182

0.85

2.31

4.2

4.8

21.1

22.4

0.75

149

2141

(3003694) ABO and Rh group [Type] in Blood

318

3691

0.84

2.28

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

120

1.92

2.23

1.6

1.5

—

(3012501) Base excess in Blood by calculation

360

1.51

2.17

5.6

4.0

mmol/l

2.7

2.8

0.08

224

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.62

2.17

1.5

1.1

—

(3013290) Carbon dioxide [Partial pressure] in Blood

361

1.50

2.14

5.6

4.0

kpa

5.2

5.0

0.63

350

(3034092) Cytoplasmic Ig cells/100 cells in Blood

4.28

2.14

22.7

10.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

144

1.81

2.12

1.0

1.1

u/ml

1.5

1.7

0.04

(3013650) Neutrophils [#/volume] in Blood by Automated count

910

8398

1.12

2.11

11.1

7.4

e9/l

4.7

4.4

3.06

820

7185

(40768800) Prostate Pathology biopsy report

304

0.49

2.11

1.1

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

641

7015

0.88

2.07

2.1

pmol/l

89.4

92.2

0.96

357

3605

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

283

3289

0.84

2.06

1.6

mmol/l

1.4

1.3

0.51

243

2735

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

316

3638

0.85

2.06

2.4

2.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

389

1.47

2.06

1.3

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

168

1.73

2.05

1.6

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.07

2.05

1.8

2.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

3.99

2.03

1.0

mg/g

8.1

6.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

131

1027

1.29

2.02

1.7

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

343

1.49

1.99

1.8

1.3

iu/l

25.5

25.7

0.01

289

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

110

845

1.31

1.98

7.1

6.4

mmol/l

25.3

24.7

1.20

110

833

(3019069) Monocytes/100 leukocytes in Blood

732

6691

1.13

1.98

7.3

5.4

8.5

8.8

1.33

695

6109

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

612

5534

1.13

1.97

3.6

3.3

ng/l

2163.2

2307.9

0.26

541

4708

(3006504) Eosinophils/100 leukocytes in Blood

728

6656

1.13

1.96

6.7

5.1

2.7

2.8

0.60

695

6045

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.33

1.95

1.9

1.6

ng/l

84.9

101.4

—

(4035726)

1136

0.75

1.95

1.3

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.74

1.93

1.0

—

(3022621) pH of Urine by Test strip

148

1188

1.26

1.90

4.0

3.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

751

6890

1.12

1.90

7.1

5.3

25.6

25.8

0.14

713

6247

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

800

7367

1.12

1.89

6.7

5.3

mmol/l

1.2

2.71

725

6487

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

202

1679

1.22

1.89

1.8

1.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

150

1.73

1.88

1.0

u/ml

4.8

7.7

0.67

(3018010) Neutrophils/100 leukocytes in Blood

737

6761

1.12

1.86

6.8

5.1

59.6

59.1

0.48

705

6171

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

277

0.50

1.86

1.4

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

499

0.63

1.81

1.3

1.5

—

(3002385) Erythrocyte distribution width [Ratio]

1134

11943

0.90

1.79

28.1

19.0

14.1

13.9

1.99

1105

11523

(3022096) Basophils/100 leukocytes in Blood

703

6451

1.12

1.76

6.4

5.1

0.6

1.36

669

5865

(3004716) Salmonella sp identified in Stool by Organism specific culture

661

1.32

1.73

1.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

869

8073

1.11

1.73

6.8

5.8

mmol/l

1.2

1.12

753

6583

(3012516) Albumin [Mass/volume] in Urine

388

4334

0.87

1.71

3.1

mg/l

990.5

285.8

1.23

267

2719

(3008295) Osmolality of Serum or Plasma

155

1.68

1.70

1.6

1.2

mosm/kgh2o

275.9

276.5

0.04

103

(3047007) Chlamydophila sp Ab [Presence] in Serum

148

1.69

1.68

1.1

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1507

15620

0.91

1.66

27.0

19.1

mmol/l

4.0

0.19

1432

14960

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.38

1.66

1.1

2.1

ug/l

14.3

213.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

106

833

1.28

1.66

7.1

7.2

mmol/l

24.8

24.4

0.53

745

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

106

1322

0.79

1.60

1.5

1.7

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

1.84

1.60

1.3

1.2

nmol/l

1.1

1.4

0.49

(3045424) Erythrocytes [Presence] in Urine

209

0.47

1.59

1.8

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

143

1.68

1.59

1.3

e6/l

162455.3

206028.7

0.09

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

261

0.53

1.59

1.3

1.4

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

1.90

1.58

1.6

4.3

u/l

253.9

217.6

0.25

(3000570) Elastase.pancreatic [Mass/mass] in Stool

404

1.39

1.57

1.6

1.5

ug/g

245.7

262.9

0.27

245

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

260

0.53

1.57

1.3

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

175

1.60

1.55

1.2

1.1

u/ml

8.3

1.2

0.65

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

259

0.54

1.55

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

259

0.54

1.55

1.3

1.4

—

(3023419) Bacteria identified in Sputum by Culture

191

1.57

1.55

1.4

2.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.33

1.52

10.2

7.3

mmol/l

4.6

6.8

—

(3016018) Differential panel - Cerebral spinal fluid

100

1.80

1.51

1.4

1.1

—

(3036489) Thrombin time

450

1.36

1.51

1.8

2.0

19.8

21.8

3.96

405

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.15

1.49

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1508

15589

0.91

1.49

27.2

19.0

mmol/l

139.3

139.5

1.75

1436

14960

(3045414) Leukocytes [Presence] in Urine

638

0.71

1.48

2.2

2.0

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.07

1.48

1.7

2.4

u/ml

714.3

1150.1

0.98

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1.84

1.44

1.1

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.72

1.43

2.0

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

211

0.52

1.39

1.3

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

221

1.49

1.39

1.3

1.4

—

(3017569) Oxygen content in Arterial blood

2.17

1.38

1.3

3.1

—

(3026782) Osmolality of Urine

372

3336

1.13

1.38

4.0

2.7

mosm/kgh2o

527.8

555.0

1.36

319

2806

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

126

1.67

1.38

1.1

1.2

—

(3000494) Fungus identified in Specimen by Culture

179

1523

1.18

1.36

1.3

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

2.19

1.36

1.1

1.0

—

(40761536) Microorganisms panel - Urine sediment

107

1304

0.81

1.35

5.4

3.8

—

(3027945) Reticulocytes/100 erythrocytes in Blood

247

2159

1.15

1.35

2.3

1.8

0.22

218

1817

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.86

1.33

1.6

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

207

0.53

1.32

1.3

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

619

1.28

1.32

2.4

1.8

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.03

1.31

1.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

516

4730

1.11

1.31

2.6

2.2

mg/l

3.6

3.2

1.89

459

3911

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

736

0.75

1.31

2.2

1.9

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1124

0.80

1.31

1.8

1.7

—

(40767503) Oxygen content in Capillary blood by calculation

316

1.39

1.31

2.8

2.5

15.4

15.8

0.22

146

(3033705) Calcium.ionized [Moles/volume] in Venous blood

325

1.39

1.30

3.1

2.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

121

1.65

1.29

1.1

1.6

—

(3005033) Fetal Nuchal fold Thickness US

205

0.53

1.29

1.3

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.84

1.28

1.6

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

201

1.49

1.28

3.6

2.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

145

1.59

1.27

1.2

1.3

pmol/l

300.5

266.3

0.11

112

(3052851) Hemolysis interference index of Serum or Plasma

508

1.30

1.27

2.9

3.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.28

1.26

3.5

2.8

—

(3013727) Leukocytes other/100 leukocytes in Blood

2.00

1.26

2.1

5.9

59.0

50.9

0.67

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.39

1.24

1.0

—

(3023410) Appearance of Cerebral spinal fluid

100

1.70

1.22

1.3

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

167

0.54

1.18

2.2

2.4

—

(3014051) Protein [Presence] in Urine by Test strip

357

0.67

1.18

2.0

2.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.10

1.18

1.4

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

332

0.66

1.16

1.4

—

(3020650) Glucose [Presence] in Urine

0.00

1.15

0.0

1.6

—

(3042733) HLA Ab [Presence] in Serum

2.49

1.14

6.0

4.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

182

1.48

1.14

1.2

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

659

6994

0.92

1.13

4.7

4.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

367

3338

1.11

1.10

2.9

3.0

mmol/l

2.5

0.74

314

2818

(3000475) Leukocytes [#/volume] in Synovial fluid

345

1.33

1.09

1.6

e6/l

11375.3

21950.2

1.51

248

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.38

1.08

1.6

1.4

umol/l

45.0

43.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

586

1.25

1.05

2.5

2.0

ug/l

1317.3

511.9

0.45

547

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1480

15196

0.93

1.04

24.9

15.8

mg/l

26.7

27.7

0.53

1301

12278

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

254

1.38

1.02

1.5

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.83

1.01

1.4

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

589

1.24

1.01

6.5

4.6

—

(3017181) Myelocytes/100 leukocytes in Blood

115

972

1.19

1.01

3.5

1.1

1.0

0.10

319

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

1.61

0.98

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

115

1.56

0.98

1.6

1.3

—

31.7

—

(21494434) Karyotype in Bone marrow

135

0.52

0.98

1.1

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

669

0.79

0.97

2.0

1.8

—

(4133840)

0.00

0.97

0.0

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.00

0.97

0.0

1.4

—

2.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

163

1422

1.15

0.97

2.7

2.3

g/l

65.8

0.01

150

1226

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

0.00

0.97

0.0

1.3

—

0.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

156

1.47

0.97

1.0

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

846

8841

0.93

0.97

4.1

2.9

u/l

54.1

51.4

0.23

786

8016

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.74

0.95

1.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1.69

0.94

1.0

ng/l

323.7

358.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

327

0.70

0.94

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

300

2730

1.11

0.91

1.3

1.2

u/ml

0.9

1.8

2.43

666

(3002256) Pathology report gross observation

156

1765

0.87

0.90

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1.66

0.90

1.0

ng/l

789.1

584.8

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1.66

0.90

1.0

ng/l

41.4

51.8

—

(3022806) Fractional oxyhemoglobin in Capillary blood

201

1.39

0.90

2.1

1.9

90.1

88.7

1.01

201

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

810

1.19

0.88

7.0

2.9

mmol/l

24.9

24.0

1.73

717

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

492

1.24

0.88

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

492

1.24

0.88

1.5

1.3

—

(3025159) Blasts/100 leukocytes in Blood

822

1.18

0.86

3.5

3.7

0.0

0.5

0.78

241

(36304419) Bacteria [Presence] in Urine

459

4277

1.08

0.85

4.2

3.1

—

(3032080) INR in Blood by Coagulation assay

730

6925

1.07

0.84

12.3

11.1

inr

1.2

1.4

2.80

169

1703

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

148

1299

1.14

0.84

2.9

2.3

u/l

37.0

34.6

0.15

120

1082

(3051651) Icteric interference index of Serum or Plasma

1.59

0.83

2.5

3.0

—

(3045142) Bone marrow Pathology biopsy report

138

0.58

0.83

1.0

1.2

—

(3024928) Oxygen saturation in Venous blood

344

1.28

0.83

5.6

2.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

107

919

1.17

0.81

2.3

2.5

—

(3022145) Colonoscopy Study observation

146

1285

1.14

0.80

1.4

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

589

1.21

0.80

1.1

—

246.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.70

0.80

1.0

1.1

miu/ml

1293.5

1584.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.57

0.80

1.9

4.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

0.79

0.0

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

280

0.71

0.78

1.6

1.3

e6/l

858.6

2457.2

1.42

207

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

233

1.33

0.78

1.1

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

233

1.33

0.78

3.0

2.1

mg/l

33.1

24.9

0.36

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

124

0.56

0.77

1.4

1.1

—

(3003338) MCHC [Mass/volume]

1317

12753

1.06

0.77

31.9

20.8

g/l

330.0

331.0

3.51

1259

12483

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.00

0.77

0.0

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

133

1170

1.14

0.75

3.5

3.4

mmol/l

1.2

0.12

111

967

(3052592) Norovirus Ag [Presence] in Stool

1.69

0.75

1.2

1.4

—

(3011412) CD3 cells [#/volume] in Blood

107

1.49

0.75

1.6

2.3

e9/l

0.9

1.1

0.30

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

582

6107

0.94

0.74

2.5

2.1

nmol/l

76.9

78.1

0.48

537

5185

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.08

0.74

1.2

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

149

1664

0.89

0.74

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.60

0.74

1.7

2.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.84

0.73

2.4

2.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.84

0.73

1.1

1.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

158

1.39

0.73

1.2

1.6

70.2

68.5

0.08

105

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

176

1.36

0.71

1.1

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.61

0.71

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

489

1.21

0.70

2.3

1.7

—

(3008898) HLA-B27 [Presence]

345

1.25

0.69

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

329

0.75

0.68

1.3

1.4

—

(3028271) Lactate [Moles/volume] in Capillary blood

248

1.29

0.67

2.2

1.9

mmol/l

2.0

1.7

0.40

243

(3023520) Reticulocytes [#/volume] in Blood

137

1525

0.89

0.66

1.9

2.3

e9/l

73.3

67.4

0.96

107

1187

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

119

1.43

0.66

1.2

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

179

1.34

0.65

1.1

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

145

1.38

0.64

1.2

nmol/l

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.61

0.64

1.3

1.1

u/l

119.3

410.5

—

(40768795) Lymph node Pathology biopsy report

128

0.62

0.64

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

376

1.22

0.63

1.6

iu/ml

0.3

16.4

0.57

(3029075) Extractable nuclear Ab panel - Serum

1.72

0.63

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

490

0.81

0.63

1.8

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

257

0.73

0.63

1.5

1.3

e6/l

170576.0

80614.2

0.22

159

(3044941) Cell count panel - Synovial fluid

224

1.29

0.63

1.6

1.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1128

10923

1.05

0.63

6.2

4.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

727

1.16

0.62

2.9

3.3

pmol/l

4.5

0.21

620

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

146

1.37

0.62

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

830

1.15

0.62

1.1

1.2

—

(3045788) Cell count panel - Pleural fluid

233

0.73

0.62

1.4

—

(40768793) Breast Pathology biopsy report

289

0.76

0.61

1.5

1.3

—

(40768446) Kidney Pathology biopsy report

1.66

0.61

2.4

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

164

1.34

0.61

1.2

u/ml

1.9

4.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

187

1705

1.10

0.60

5.0

3.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

201

1841

1.10

0.59

1.3

1.2

u/ml

7.4

13.8

0.95

641

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

122

1.39

0.59

1.2

1.3

ug/l

3.7

3.2

0.37

110

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

122

1.39

0.59

1.1

1.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

131

1175

1.12

0.58

2.2

2.9

ml/min/173m2

64.9

59.2

0.91

517

(3022689) Creatine [Moles/volume] in Urine

0.00

0.58

0.0

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.52

0.58

3.1

3.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

157

1.34

0.58

3.0

1.9

—

(3033658) Prothrombin time (PT) actual/Normal

356

3758

0.94

0.56

4.7

3.6

88.3

83.5

2.59

345

3632

(3015171) Extractable nuclear Ab [Units/volume] in Serum

419

1.19

0.56

1.3

1.2

u/ml

0.3

0.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

337

1.22

0.56

1.3

1.4

—

(3017732) Neutrophils [#/volume] in Blood

940

0.88

0.56

5.2

2.8

e9/l

4.4

4.3

0.12

673

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.43

0.55

1.3

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

773

1.14

0.55

1.2

iu/ml

70.7

135.0

1.25

306

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

1.54

0.54

1.4

1.7

mmol/l

12.2

7.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.54

0.54

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.54

0.54

1.0

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

123

0.65

0.54

17.0

2.8

14.6

13.2

—

123

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

203

1.28

0.54

1.2

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

302

1.22

0.54

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.57

0.54

1.2

110.8

107.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

412

1.19

0.53

1.9

1.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

101

898

1.13

0.53

3.7

3.6

0.1

0.45

286

(36660697) Celiac disease serology panel - Serum

108

966

1.12

0.52

1.3

1.2

—

(4027681)

1.51

0.52

1.1

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.50

0.51

1.2

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

1.50

0.51

1.5

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

204

1886

1.08

0.51

1.8

1.4

—

(4024509)

142

0.70

0.47

2.5

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.41

0.46

1.1

1.4

—

(3024263) Appearance of Synovial fluid

1.41

0.46

1.7

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

578

1.14

0.46

2.8

2.6

—

(3037121) Protein [Mass/volume] in Urine

522

0.86

0.44

3.3

3.0

g/l

0.1

0.3

5.06

200

(4034850)

563

1.14

0.43

19.8

13.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

285

2691

1.06

0.42

2.9

2.3

umol/l

10.6

11.8

2.61

264

2414

(3037556) Urate [Mass/volume] in Serum or Plasma

1.56

0.42

1.4

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.41

0.0

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.41

0.0

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.41

0.0

1.3

—

(40768806) Pleura Pathology biopsy report

227

0.79

0.41

1.8

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

140

1.28

0.41

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.35

0.40

1.2

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

176

1.25

0.40

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

303

0.82

0.40

1.8

1.4

g/l

30.0

29.6

0.05

266

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

240

1.21

0.40

1.2

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.33

0.40

1.3

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

1.33

0.40

1.0

1.3

nmol/l

137.0

130.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

2.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

852

0.90

0.40

2.7

2.1

nmol/l

10.4

11.8

0.80

732

(4010399)

977

0.90

0.40

1.6

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

1.36

0.39

1.8

2.8

46.9

37.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

159

1.26

0.39

1.1

1.6

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.39

0.0

3.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

136

0.73

0.38

1.0

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

169

1.24

0.37

1.1

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

437

4520

0.96

0.37

3.2

2.9

mmol/l

7.0

7.1

0.20

373

3655

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.35

0.37

1.4

ug/l

12.3

8.6

—

(44813793)

1.39

0.36

1.1

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

290

1.17

0.35

1.4

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.35

0.35

1.1

—

(3035880) pH of Pleural fluid

122

0.73

0.35

1.4

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

979

0.91

0.35

1.5

1.4

—

(3037756) Immunofixation for Serum or Plasma

403

0.86

0.34

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

489

1.12

0.34

2.0

1.8

u/l

37.5

37.9

0.03

418

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.34

0.33

1.3

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

263

0.83

0.33

1.4

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

198

0.80

0.33

1.1

1.5

—

(4211845)

0.67

0.33

1.5

3.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

322

1.15

0.31

1.5

—

(40768443) Skin Pathology biopsy report

609

0.90

0.31

1.3

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

119

1.26

0.31

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

156

1.22

0.30

1.2

u/ml

2.0

5.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.27

0.30

2.7

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

1.31

0.29

1.0

1.1

mg/l

334.4

243.5

0.44

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

212

1.18

0.29

1.1

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

204

1936

1.05

0.29

1.3

1.2

iu/ml

46.0

34.1

0.46

597

(3017704) Immunofixation for Urine

107

0.74

0.29

1.6

1.5

—

(3005570) Glucose [Moles/volume] in Urine

162

0.80

0.29

2.2

1.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

109

0.73

0.29

2.8

2.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

652

6650

0.97

0.28

3.2

2.7

ug/l

109.3

133.2

3.12

603

5934

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1127

11059

1.03

0.28

4.5

3.7

pmol/l

14.9

15.1

1.51

1039

9726

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

215

0.83

0.28

1.3

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

150

0.80

0.27

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

1.29

0.27

1.1

1.6

umol/l

14.3

14.4

0.01

(3051593) INR in Capillary blood by Coagulation assay

116

0.77

0.27

2.7

19.3

—

(3012441) Differential panel - Pleural fluid

225

0.84

0.27

1.6

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.21

0.26

1.0

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

653

0.91

0.26

2.6

3.1

u/ml

0.3

0.4

1.32

382

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.68

0.26

1.0

1.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

150

1.20

0.25

2.2

2.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

180

0.83

0.25

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

180

0.83

0.25

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

212

0.85

0.24

1.9

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

262

2708

0.96

0.24

3.4

2.7

e6/l

1.5

1.4

0.07

165

1579

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

207

1.16

0.24

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

480

4905

0.97

0.24

2.4

2.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

222

0.85

0.24

2.4

u/field

1.5

2.3

0.49

(3026470) Cobalt [Mass/volume] in Blood

0.74

0.24

2.2

2.0

ug/l

6.1

2.9

—

(3006462) Nitrate [Presence] in Urine

0.73

0.24

1.5

4.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

170

1.17

0.23

3.0

3.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

179

0.83

0.23

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

340

1.12

0.23

1.2

1.6

—

(3051611) Lipemic interference index of Serum or Plasma

161

1.18

0.23

3.1

3.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

391

4005

0.97

0.23

1.6

nmol/l

20.2

19.8

0.15

356

3358

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

284

0.88

0.23

1.2

u/ml

3.1

13.0

—

(3021589) Normoblasts [#/volume] in Blood

601

5865

1.03

0.23

11.0

8.9

e9/l

0.0

1.28

494

4638

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

174

1811

0.95

0.22

2.8

3.8

u/l

225.3

250.5

3.21

165

1663

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

294

0.88

0.22

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

190

1.16

0.22

1.2

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

332

1.11

0.22

1.2

1.6

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

5.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

0.00

0.21

0.0

1.0

—

0.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.21

0.0

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.19

0.21

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

219

1.14

0.21

1.7

1.6

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.21

0.0

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

257

1.13

0.21

2.3

1.4

u/l

8.9

9.3

0.05

208

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

219

0.86

0.21

1.2

—

5.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

101

0.79

0.21

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

166

0.84

0.21

1.1

—

(1002224) Polysomnography panel

362

1.10

0.21

1.1

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.21

0.0

1.3

—

(44806071)

0.00

0.21

0.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

1.7

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

(3000492) Spirometry study

107

1124

0.95

0.20

1.6

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.20

0.0

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.20

0.0

1.3

—

5447.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.20

0.0

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

165

0.84

0.20

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

133

0.82

0.20

1.5

1.1

u/l

41.4

78.8

0.79

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.22

0.20

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

243

2499

0.97

0.19

3.5

2.9

e6/l

3.1

2.4

0.57

148

1387

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

307

1.11

0.19

1.5

1.7

iu/l

2.8

5.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

432

1.09

0.19

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

185

0.86

0.19

2.2

4.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.13

0.18

1.0

1.2

—

(3030467) Casts [#/volume] in Urine by Automated count

452

4410

1.03

0.18

4.4

3.2

e6/l

0.4

0.5

1.22

368

3406

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

289

1.10

0.18

1.3

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

337

1.10

0.18

1.7

—

(42870588) Differential panel, method unspecified - Blood

499

4879

1.02

0.17

6.0

5.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.14

0.17

1.1

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

861

1.06

0.17

3.6

3.3

1.3

0.6

0.86

215

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

647

1.06

0.17

2.1

2.2

g/l

7.2

7.6

0.95

445

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

647

1.06

0.17

2.1

2.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

647

1.06

0.17

2.1

2.2

g/l

3.6

3.8

0.59

425

(3024891) Influenza virus A+B Ag [Presence] in Specimen

473

1.08

0.17

1.4

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

183

0.87

0.17

1.4

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.17

0.16

1.0

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

297

0.90

0.16

1.6

1.3

miu/ml

208.8

218.9

—

119

(3007164) IgA [Mass/volume] in Serum or Plasma

242

2346

1.03

0.16

1.5

1.3

g/l

2.6

0.08

140

1349

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.12

0.16

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.12

0.16

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.12

0.16

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

708

1.06

0.16

2.0

1.7

g/l

1.4

1.5

0.16

619

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

203

0.88

0.16

1.3

1.2

u/ml

170.3

276.8

1.25

114

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.11

0.16

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.11

0.16

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.11

0.16

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.78

0.15

1.0

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.78

0.15

1.0

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

1.12

0.15

1.6

1.1

u/l

30.8

19.6

—

(3034770) Mitochondria Ab [Titer] in Serum

316

0.91

0.15

1.1

—

1256.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

181

0.88

0.15

1.4

1.3

—

(3011648) Oxygen content in Venous blood

102

1.17

0.14

2.8

1.5

10.7

10.6

0.03

102

(44790048)

159

1.13

0.14

1.2

1.5

—

(44790047)

159

1.13

0.14

1.2

1.5

—

(44790049)

159

1.13

0.14

1.2

1.5

—

(44806118)

159

1.13

0.14

1.2

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

128

0.86

0.14

1.2

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.83

0.13

1.5

—

(3042631) Mycobacterium sp identified in Specimen

208

1.10

0.13

1.9

2.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

103

1.16

0.13

2.3

2.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

122

1.14

0.13

1.3

1.8

—

(3014271) Vancomycin [Susceptibility]

148

0.87

0.13

2.5

3.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1185

11719

1.01

0.12

7.8

6.5

u/l

79.8

81.5

0.36

1110

10753

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

123

1.13

0.12

1.2

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

176

1799

0.97

0.11

4.4

3.3

ng/l

260.5

314.6

0.81

165

1631

(3005719) IgG [Mass/volume] in Serum or Plasma

903

1.04

0.11

2.7

g/l

10.9

10.7

0.09

801

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

141

1367

1.03

0.11

2.0

1.9

g/l

0.2

0.83

130

1234

(3004789) Transferrin [Mass/volume] in Serum or Plasma

252

2463

1.02

0.11

3.0

2.2

g/l

2.4

2.3

1.68

234

2200

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

330

3341

0.98

0.10

4.7

4.2

ng/l

629.2

394.6

0.19

260

2859

(3048929) Epstein Barr virus Ab [Presence] in Serum

330

0.94

0.10

1.3

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

798

8016

0.99

0.09

3.3

2.8

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.04

0.09

1.2

—

(3022313) Gas panel - Capillary blood

741

1.04

0.09

4.2

3.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

144

0.90

0.09

1.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

652

0.96

0.08

1.4

1.3

—

38.9

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

213

1.08

0.08

2.2

3.8

u/ml

35.7

46.0

0.25

208

(3025130) Human papilloma virus identified in Specimen

123

0.89

0.08

2.3

1.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.03

0.08

1.3

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

126

1.11

0.08

1.2

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

0.80

0.08

1.6

1.4

nmol/l

1.0

1.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

228

2309

0.98

0.08

3.0

2.3

19.1

21.0

1.25

190

1861

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

596

1.04

0.08

2.2

2.3

g/l

3.0

3.2

1.32

437

(40760888) Immunoglobulin light chains.free panel - Serum

400

1.05

0.07

4.0

3.0

—

(3047189) Immunofixation for 24 hour Urine

0.82

0.07

3.0

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

265

0.94

0.07

3.1

3.3

62.6

60.1

0.85

265

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

183

0.93

0.07

1.4

1.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

1.06

0.07

1.6

1.1

u/l

111.3

91.5

—

(40768441) Liver Pathology biopsy report

1.06

0.07

1.4

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

137

1.09

0.07

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

167

1640

1.02

0.05

2.8

3.6

ug/l

6.4

23.6

2.06

141

1372

(3023430) Cat dander IgE Ab [Units/volume] in Serum

110

0.91

0.05

1.0

1.1

u/ml

2.1

6.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

217

1.06

0.05

1.4

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

128

1297

0.98

0.05

4.2

3.2

ng/l

94.2

94.4

0.01

108

1049

(3049717) Cytology report of Urine Cyto stain

631

1.03

0.05

2.4

2.8

—

(4306422)

139

1.08

0.05

1.3

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

100

1.10

0.05

1.1

1.2

—

(3000330) Specific gravity of Urine by Test strip

974

0.98

0.04

5.5

3.8

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

465

1.03

0.04

1.9

2.3

g/l

0.0

0.1

0.70

394

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

451

0.97

0.04

2.0

2.3

g/l

0.0

0.00

383

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

531

0.98

0.03

3.8

2.9

ratio

1.3

2.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

189

0.95

0.03

1.9

1.3

u/ml

109.8

112.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

615

1.02

0.03

2.2

g/l

10.3

10.5

0.16

483

(3014148) Varicella zoster virus Ab [Titer] in Serum

118

0.93

0.03

1.0

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

260

1.04

0.02

1.5

1.6

nmol/l

43.7

40.9

0.16

250

(3030905) Polymorphonuclear cells [#/volume] in Blood

258

0.97

0.02

2.6

3.2

e9/l

4.8

4.5

0.46

258

(4268621)

107

0.93

0.02

2.3

2.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

385

3851

1.00

0.02

2.9

2.6

umol/l

358.6

9921.4

17.90

340

3197

(4094501)

297

0.97

0.02

1.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.07

0.01

1.5

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

123

1.05

0.01

1.3

1.6

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

176

0.96

0.01

1.0

1.1

—

11.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

544

0.99

0.00

3.8

2.9

mg/l

45.2

73.3

0.60

441

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

544

0.99

0.00

2.3

g/l

0.4

1.3

2.80

429

(3034860) Kappa light chains.free [Mass/volume] in Serum

544

0.99

0.00

3.8

2.9

mg/l

75.0

182.7

0.50

439

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

134

1.04

0.00

1.2

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

113

0.97

0.00

1.7

1.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

166

1.02

0.00

2.6

2.0

u/ml

337.0

273.6

0.06

158

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

192

0.99

0.00

1.1

—

(4281824)

115

1.04

0.00

1.2

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

115

0.95

0.00

1.3

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

115

0.95

0.00

1.3

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

115

0.95

0.00

1.3

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

431

0.99

0.00

1.4

1.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

589

1.00

0.00

2.6

3.0

u/ml

384.4

8325.8

0.97

493

(3007566) Smooth muscle Ab [Titer] in Serum

304

1.02

0.00

1.2

1.1

titre

73.3

90.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

151

0.99

0.00

3.3

3.0

66.7

57.8

—

(3004588) Protein electrophoresis panel - Serum or Plasma

118

1174

1.00

0.00

2.7

2.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

847

1.00

0.00

1.3

1.8

g/l

1.4

1.6

0.78

692

(3013707) Erythrocyte sedimentation rate by Westergren method

1098

10943

1.00

0.00

4.5

3.7

mm/h

15.9

14.7

1.66

1022

9852

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

120

1.00

0.00

1.0

1.4

—

260.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

563

1.01

0.00

3.2

3.4

nmol/l

0.8

0.43

427

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

511

0.99

0.00

1.9

2.2

g/l

38.4

36.9

0.92

401

(3021788) Differential panel - Synovial fluid

249

1.00

0.00

1.4

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

107

1.02

0.00

2.2

2.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

442

0.99

0.00

2.0

2.3

g/l

0.0

0.00

381

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.0

1.0

—

159.5

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

5.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.00

0.0

2.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.96

0.00

1.1

1.3

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.2

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

2.8

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.94

0.00

1.3

1.9

—

70.6

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

1.01

0.00

1.1

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.95

0.00

1.0

1.4

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.6

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.95

0.00

1.0

1.4

—

(3004451) EKG impression Narrative

0.92

0.00

1.3

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.89

0.00

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.01

0.00

9.3

6.9

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate

0.91

0.00

1.0

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

1.00

0.00

1.0

—

15.4

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.01

0.00

1.2

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.0

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.01

0.00

1.0

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.0

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint Z21_PROBL_RELATED_MEDICAL_FACILITI_OTH_HEALTH_CARE and mortality.

Females

Parameter	HR [95% CI]	p-value
Z21_PROBL_RELATED_MEDICAL_FACILITI_OTH_HEALTH_CARE	2.28 [2.07, 2.52]	< 0.001
Birth year	0.997 [0.99, 1.0]	0.429

During the follow-up period (1.1.1998 — 31.12.2019), 13024 out of 18209 females with Z21_PROBL_RELATED_MEDICAL_FACILITI_OTH_HEALTH_CARE died.

Males

Parameter	HR [95% CI]	p-value
Z21_PROBL_RELATED_MEDICAL_FACILITI_OTH_HEALTH_CARE	2.876 [2.5, 3.31]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 11614 out of 15538 males with Z21_PROBL_RELATED_MEDICAL_FACILITI_OTH_HEALTH_CARE died.

Mortality risk

Mortality risk for people of age

years, who have Z21_PROBL_RELATED_MEDICAL_FACILITI_OTH_HEALTH_CARE.

N-year risk	Females	Males
1	0.26%	0.641%
5	1.391%	3.286%
10	3.355%	8.02%
15	6.24%	14.528%
20	10.962%	23.933%

Relationships between endpoints

↥

Index endpoint: Z21_PROBL_RELATED_MEDICAL_FACILITI_OTH_HEALTH_CARE – Problems related to medical facilities and other health care

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Problems related to medical facilities and other health care

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints